西亚试剂优势供应上万种化学试剂产品,欢迎各位新老客户咨询、选购!

登录

¥0.00

联系方式:400-990-3999 / 邮箱:sales@xiyashiji.com

西亚试剂 —— 品质可靠,值得信赖

西亚试剂:Short Telomeres and Stem Cell Exhaustion Model Duchenne Mus

Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Alessandra Sacco1, 4, 5, Foteini Mourkioti1, 4, Rose Tran1, Jinkuk Choi2, Michael Llewellyn3, Peggy Kraft1, Marina Shkreli2, Scott Delp3, Jason H. Pomerantz1, 6, , , Steven E. Artandi2 and Helen M. Blau1, ,

1 Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA

2 Department of Medicine, Cancer Biology Program, Stanford University School of Medicine, Stanford, CA 94305, USA

3 BioX Program, James H. Clark Center for Biomedical Engineering and Science, Stanford University, CA 94305, USA

Received 18 May 2010;  revised 18 September 2010;  accepted 2 November 2010.  Published online: December 9, 2010.  Available online 9 December 2010.

Summary

In Duchenne muscular dystrophy (DMD), dystrophin mutation leads to progressive lethal skeletal muscle degeneration. For unknown reasons, dystrophin deficiency does not recapitulate DMD in mice (mdx), which have mild skeletal muscle defects and potent regenerative capacity. We postulated that human DMD progression is a consequence of loss of functional muscle stem cells (MuSC), and the mild mouse mdx phenotype results from greater MuSC reserve fueled by longer telomeres. We report that mdx mice lacking the RNA component of telomerase (mdx/mTR) have shortened telomeres in muscle cells and severe muscular dystrophy that progressively worsens with age. Muscle wasting severity parallels a decline in MuSC regenerative capacity and is ameliorated histologically by transplantation of wild-type MuSC. These data show that DMD progression results, in part, from a cell-autonomous failure of MuSC to maintain the damage-repair cycle initiated by dystrophin deficiency. The essential role of MuSC function has therapeutic implications for DMD.